Posted On: 12/08/2014 8:02:37 AM
Post# of 30070

Re: DandyRitter #12514
and therein lies the LymPro challenge
1.) outright BP sale
2.) inlicensure
3.) spin off
4.) JV partnership
Gerald has not clarified which direction
may options, but no clear cut path - yet............
1.) outright BP sale
2.) inlicensure
3.) spin off
4.) JV partnership
Gerald has not clarified which direction
may options, but no clear cut path - yet............

